In the wake of the COVID-19 pandemic, recent years’ data is not a reliable predictor of future mortality. Using the CDC’s death data and USCB’s population estimates, 69É«ÇéƬ has conducted a thorough analysis of emerging data to identify how US m...
Fraud is a lingering concern for US life insurance carriers, presenting a myriad of challenges. Through the 2024 US Life Insurance Fraud Survey, conducted by 69É«ÇéƬ and MIB, 25 carriers shared their pain points, and detection and prevention practices. The resulting insi...
Read More
Growing evidence links metabolic syndrome and psychiatric conditions. Dual-purpose treatments can enable insurers to provide more targeted and effective solutions, potentially reducing long-term costs associated with chronic comorbidities.
Read More
As medical advances promise to revolutionize cancer detection and treatment, Japan’s experience with comprehensive cancer coverage may offer insights into the opportunities and challenges in other markets.
Read More69É«ÇéƬ produces a number of specialized publications featuring expert opinion and analysis. Explore our public collection or contact us for whitepapers, webinars, and other resources.
Explore the industry's premier medical underwriting publication.
Explore the ReFlections SeriesInvestigate product development trends and developments from around the world.
Explore the Product Trends Series
